Goldman Sachs’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$333K Buy
112,084
+64,902
+138% +$193K ﹤0.01% 4470
2025
Q1
$153K Sell
47,182
-6,548
-12% -$21.2K ﹤0.01% 4734
2024
Q4
$212K Buy
53,730
+13,312
+33% +$52.6K ﹤0.01% 4645
2024
Q3
$312K Buy
40,418
+27,252
+207% +$211K ﹤0.01% 4326
2024
Q2
$67.7K Sell
13,166
-48,995
-79% -$252K ﹤0.01% 4537
2024
Q1
$505K Buy
+62,161
New +$505K ﹤0.01% 3983
2022
Q3
Sell
-10,102
Closed -$57K 5674
2022
Q2
$57K Sell
10,102
-48,125
-83% -$272K ﹤0.01% 5255
2022
Q1
$503K Buy
58,227
+16,739
+40% +$145K ﹤0.01% 4563
2021
Q4
$462K Sell
41,488
-15,269
-27% -$170K ﹤0.01% 4573
2021
Q3
$735K Buy
56,757
+29,183
+106% +$378K ﹤0.01% 4167
2021
Q2
$456K Buy
27,574
+15,449
+127% +$255K ﹤0.01% 4483
2021
Q1
$208K Sell
12,125
-452
-4% -$7.75K ﹤0.01% 4817
2020
Q4
$197K Sell
12,577
-176
-1% -$2.76K ﹤0.01% 4281
2020
Q3
$243K Sell
12,753
-19,992
-61% -$381K ﹤0.01% 3992
2020
Q2
$449K Sell
32,745
-90,626
-73% -$1.24M ﹤0.01% 3648
2020
Q1
$1.31M Buy
123,371
+104,153
+542% +$1.11M ﹤0.01% 2973
2019
Q4
$359K Buy
19,218
+9,127
+90% +$170K ﹤0.01% 3799
2019
Q3
$106K Sell
10,091
-1,859
-16% -$19.5K ﹤0.01% 4038
2019
Q2
$91K Sell
11,950
-69,367
-85% -$528K ﹤0.01% 4007
2019
Q1
$896K Buy
81,317
+71,281
+710% +$785K ﹤0.01% 3320
2018
Q4
$51K Buy
+10,036
New +$51K ﹤0.01% 3971
2018
Q3
Sell
-11,513
Closed -$52K 4252
2018
Q2
$52K Sell
11,513
-9,758
-46% -$44.1K ﹤0.01% 4061
2018
Q1
$114K Sell
21,271
-56,504
-73% -$303K ﹤0.01% 3992
2017
Q4
$306K Buy
77,775
+31,467
+68% +$124K ﹤0.01% 3648
2017
Q3
$202K Sell
46,308
-33,946
-42% -$148K ﹤0.01% 3881
2017
Q2
$377K Sell
80,254
-18,545
-19% -$87.1K ﹤0.01% 3678
2017
Q1
$1.63M Buy
98,799
+24,434
+33% +$403K ﹤0.01% 2856
2016
Q4
$753K Buy
74,365
+59,979
+417% +$607K ﹤0.01% 3233
2016
Q3
$194K Sell
14,386
-37,862
-72% -$511K ﹤0.01% 3947
2016
Q2
$1.09M Buy
+52,248
New +$1.09M ﹤0.01% 2902
2016
Q1
Sell
-13,848
Closed -$151K 4632
2015
Q4
$151K Sell
13,848
-39,614
-74% -$432K ﹤0.01% 3847
2015
Q3
$799K Buy
+53,462
New +$799K ﹤0.01% 3040